Inactivation of Viruses in Blood and Plasma Products
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
To ensure that current plasma-derived, vaccine, and recombinant biotherapeutics are safe, complementary safety strategies to reduce the risk of virus contamination were developed and implemented.
“To ensure that current plasmaderived, vaccine, and recombinant biotherapeutics are safe, complementary safety strategies to reduce the risk of virus contamination were developed and implemented [9][10][11] .”
From Viral contamination in biologic manufacture and implications for emerging therapies (2020) · cites this paper as [10]
Cited by
Sorted by citations
Viral contamination in biologic manufacture and implications for emerging therapies
Barone, P. W., Wiebe, M. E., Leung, J. C., Hussein, I. T. M., Keumurian, F. J., Bouressa, J., Brussel, A., Chen, D., Chong, M., Dehghani, H., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0507-2 · Cited by 212 · see citing works
- Authors
- Suomela, H.
- Affiliations
- Finnish Red Cross (FI)
- Corresponding author
- Suomela, Hannu
- Venue
- Transfusion Medicine Reviews
- Publisher
- Elsevier BV
- Published
- 1993-01
- Volume
- 7
- Issue
- 1
- Pages
- 42-57
- ISSN
- 0887-7963 (ISSN-L)
- OpenAlex
- W2094147223
- Cited by
- 53
- References
- 0
- Citations by year
- 2024: 2 · 2023: 1 · 2022: 1 · 2020: 1 · 2018: 1 · 2016: 1 · 2015: 1 · 2012: 1
- FWCI
- 4.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Transfusion Medicine Reviews (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Biochemistry › Blood transfusion and management
- Social Sciences › Business, Management and Accounting › Management of Technology and Innovation › Blood donation and transfusion practices
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Microbial Inactivation Methods
- Keywords
- virus inactivation, blood products, plasma-derived products, transfusion-transmitted infections, viral hepatitis, AIDS, parvovirus, cytomegalovirus, Epstein-Barr virus, factor VIII concentrate, intravenous immunoglobulin, intramuscular immunoglobulin, albumin, donor screening, transfusion safety
- MeSH terms
- Antiviral Agents, Blood, Blood Donors, Chromatography, Chemical Fractionation, Gamma Rays, Hot Temperature, Humans, Propiolactone, Safety, Ultraviolet Rays, Virus Diseases, Viruses, Immunoglobulins, Intravenous, Transfusion Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
